Findings on oral drug to be presented at San Antonio Breast Cancer Symposium

November 30, 2022

Elacestrant may improve care of metastatic ER+/HER2- tumors Contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu SAN ANTONIO (Nov. 30, 2022) — Phase III results of EMERALD, a clinical trial evaluating a novel oral drug therapy for metastatic ER-positive/HER2-negative (ER+/HER2-) breast cancer, will be presented Thursday, Dec. 8, at the San Antonio Breast Cancer Symposium (SABCS). Virginia Kaklamani, MD, […]

CPRIT adds $10.9 million to UT Health San Antonio cancer research and prevention efforts

February 17, 2022

Contact: Will Sansom, (210) 567-2579, sansom@uthscsa.edu SAN ANTONIO (Feb. 17, 2022) — The University of Texas Health Science Center at San Antonio (UT Health San Antonio) is receiving $10.9 million in new research and faculty recruitment awards announced Feb. 16 by the Cancer Prevention and Research Institute of Texas (CPRIT). The statewide cancer agency has […]

Mays Cancer Center researchers to present findings and discuss disparities during 2021’s San Antonio Breast Cancer Symposium

December 1, 2021

Treatable mutations, obesity-driven cancer and clinical trial access are among local speakers’ topics for this year’s symposium. Contact: Will Sansom, (210) 567-2579, sansom@uthscsa.edu SAN ANTONIO (Dec. 1, 2021) — Researchers from the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, will present results of multiple lines of study Dec. 7-10 […]